INHIBITION OF RAT-BRAIN MONOAMINE-OXIDASE ACTIVITY BY CEREBRAL ANTIISCHEMIC AGENT, IFENPRODIL

被引:7
作者
ARAI, Y
NAKAZATO, K
KINEMUCHI, H
TADANO, T
SATOH, N
OYAMA, K
KISARA, K
机构
[1] GRELEN PHARMACEUT CO LTD,SETAGAYA KU,TOKYO 154,JAPAN
[2] ISHINOMAKI SENSHU UNIV,FAC SCI & ENGN,BIOL CHEM LAB,ISHINOMAKI 986,JAPAN
[3] TOHOKU COLL PHARMACEUT SCI,DEPT PHARMACOL,AOBA KU,SENDAI 981,JAPAN
关键词
MONOAMINE OXIDASE (MAO); MAO-A; MAO-B; INHIBITION OF MAO; IFENPRODIL; ANTIISCHEMIC EFFECT;
D O I
10.1016/0028-3908(91)90190-M
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Ifenprodil, which is clinically used as a cerebral vasodilator, inhibited rat brain type A (MAO-A) and type B (MAO-B) monoamine oxidase activity. It did not, however, affect rat lung semicarbazide-sensitive amine oxidase. The degree of inhibition of either form of MAO vas not changed by 30 min preincubation of the enzyme preparations at 37-degrees-C with ifenprodil. Modes of inhibition of MAO-A and MAO-B by ifenprodil were competitive towards oxidation of their respective substrates, S-hydroxytryptamine and benzylamine, with Ki values of 75-mu-M for inhibition of MAO-A and 110-mu-M for inhibition of MAO-B.
引用
收藏
页码:809 / 812
页数:4
相关论文
共 13 条
[1]  
CARRON C, 1971, ARZNEI-FORSCHUNG, V21, P1992
[2]  
CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222
[3]  
CASADAMONT M, 1981, BRIT J PHARMACOL, V74, pP257
[4]   EFFECTS OF TRANSIENT FOREBRAIN ISCHEMIA AND PARGYLINE ON EXTRACELLULAR CONCENTRATIONS OF DOPAMINE, SEROTONIN, AND THEIR METABOLITES IN THE RAT STRIATUM AS DETERMINED BY INVIVO MICRODIALYSIS [J].
DAMSMA, G ;
BOISVERT, DP ;
MUDRICK, LA ;
WENKSTERN, D ;
FIBIGER, HC .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (03) :801-808
[5]   EFFECT OF ISCHEMIA ON THE INVIVO RELEASE OF STRIATAL DOPAMINE, GLUTAMATE, AND GAMMA-AMINOBUTYRIC ACID STUDIED BY INTRACEREBRAL MICRODIALYSIS [J].
GLOBUS, MYT ;
BUSTO, R ;
DIETRICH, WD ;
MARTINEZ, E ;
VALDES, I ;
GINSBERG, MD .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (05) :1455-1464
[6]   ALZHEIMERS-DISEASE AND SENILE DEMENTIA - BIOCHEMICAL CHARACTERISTICS AND ASPECTS OF TREATMENT [J].
GOTTFRIES, CG .
PSYCHOPHARMACOLOGY, 1985, 86 (03) :245-252
[7]  
HONDA H, 1987, ARCH INT PHARMACOD T, V285, P211
[8]   BLOOD-BRAIN-BARRIER MONOAMINE-OXIDASE - ENZYME CHARACTERIZATION IN CEREBRAL MICROVESSELS AND OTHER TISSUES FROM 6 MAMMALIAN-SPECIES, INCLUDING HUMAN [J].
KALARIA, RN ;
HARIK, SI .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (03) :856-864
[9]   PARTICIPATION OF BRAIN MONOAMINE-OXIDASE B FORM IN THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - RELATIONSHIP BETWEEN THE ENZYME-INHIBITION AND THE NEUROTOXICITY [J].
KINEMUCHI, H ;
ARAI, Y ;
TOYOSHIMA, Y .
NEUROSCIENCE LETTERS, 1985, 58 (02) :195-200
[10]  
KINEMUCHI H, 1984, MONOAMINE OXIDASE DI, P53